2020-2029 Report on Global Biosimilar Monoclonal Antibodies Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR2002352
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 103
-
The global Biosimilar Monoclonal Antibodies market was valued at $XX million in 2019, and Research analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Monoclonal Antibodies market.
Leading players of Biosimilar Monoclonal Antibodies including:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
Market split by Type, can be divided into:
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market split by Application, can be divided into:
Oncology
Autoimmune Disease
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Report on Global Biosimilar Monoclonal Antibodies Market market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Biosimilar Monoclonal Antibodies Market Overview1.1 Biosimilar Monoclonal Antibodies Definition
1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2014-2029)
1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2014-2029)
1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2014-2029)
1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2014-2029)
1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2014-2029)
1.7 Biosimilar Monoclonal Antibodies Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biosimilar Monoclonal Antibodies Market Segment Analysis by Player2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2017-2019)
2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2017-2019)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Monoclonal Antibodies Market Segment Analysis by Type3.1 Global Biosimilar Monoclonal Antibodies Market by Type
3.1.1 Infliximab
3.1.2 Rituximab
3.1.3 Trastuzumab
3.1.4 Adalimumab
3.1.5 Other3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2014-2019)
3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2014-2019)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2014-2019)
3.5 Leading Players of Biosimilar Monoclonal Antibodies by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Monoclonal Antibodies Market Segment Analysis by Application4.1 Global Biosimilar Monoclonal Antibodies Market by Application
4.1.1 Oncology
4.1.2 Autoimmune Disease
4.1.3 Other4.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Monoclonal Antibodies Market Segment Analysis by Sales Channel5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Monoclonal Antibodies Market Segment Analysis by Region6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2014-2029)
6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2014-2019)
6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type
6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type
6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type
6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type
6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type
6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players7.1 Celltrion
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Celltrion7.2 Pfizer (Hospira)
7.3 3SBIO7.4 Novartis (Sandoz)
7.5 Dr Reddy’s
7.6 Celgen Biopharma
7.7 Cadila Healthcare
7.8 Hisun Pharma
7.9 Torrent Pharmaceuticals
Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies8.1 Industrial Chain of Biosimilar Monoclonal Antibodies
8.2 Upstream of Biosimilar Monoclonal Antibodies
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process8.3 Downstream of Biosimilar Monoclonal Antibodies
8.3.1 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies
8.3.2 Leading Consumers of Biosimilar Monoclonal Antibodies
Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2020-2029)9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
-
The Report on Global Biosimilar Monoclonal Antibodies Market Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
A large number of Global Report on Global Biosimilar Monoclonal Antibodies Market players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
Report on Global Biosimilar Monoclonal Antibodies Market has a wide range of applications, including
It is expected that the Report on Global Biosimilar Monoclonal Antibodies Market Market will reach USD XX million by 2029.
According to the Report on Global Biosimilar Monoclonal Antibodies Market Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
The latest version of the Report on Global Biosimilar Monoclonal Antibodies Market Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
